This strain contains 18 protein-level mutations:
We identified all possible linear viral peptides affected by these mutations. Whenever it was possible, we matched the reference peptide with the mutated one. For example, D -> L mutation transformed SDNGPQNQR to SLNGPQNQR. Cases when it was not meaningful included deletions and insertions at the flanks of the peptide, e.g., HV deletion in NVTWFHAIHV peptide.
Then, we predicted binding affinities between the selected peptides and frequent HLA alleles. Predictions were made with NetMHCpan-4.1 and NetMHCIIpan-4.0. The binding affinities were classifies into three groups:
Here we report HLA-peptide interactions whose affinity was altered by at least two folds. Note that mutations with empty set of altered interactions are not showed.
Weaker binding was found for 21 epitopes, while stronger binding was found for 77 entries. There are 937 tight binders for the HLA-DRB1*11:01 in the reference immunopeptidome (IC50 affinity ≤ 50 nM); 2 of them became non-tight binders (0.2%) and 16 novel tight binders appeared (1.7%). To avoid possible divisions by zero, we used + 1 regularization term in denominators when calculating percentages.
Reference DDFTGCVIAWNSNNLDSKVGGNYNYLYRLFRKSNLKPFERDISTEIYQAGS
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated DDFTGCVIAWNSNNLDSKVGGNYNYRYRLFRKSNLKPFERDISTEIYQAGS
| Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
|---|---|---|---|---|
| HLA-DRB1*11:01 | GGNYNYLYRLFRKSN | GGNYNYRYRLFRKSN | 37 | 169 |
| HLA-DRB1*11:01 | KVGGNYNYLYRLFRKSN | KVGGNYNYRYRLFRKSN | 72 | 326 |
| HLA-DRB1*11:01 | VGGNYNYLYRLFRKSN | VGGNYNYRYRLFRKSN | 82 | 368 |
| HLA-DRB1*11:01 | KVGGNYNYLYRLFRK | KVGGNYNYRYRLFRK | 64 | 271 |
| HLA-DRB1*11:01 | SKVGGNYNYLYRLFRK | SKVGGNYNYRYRLFRK | 145 | 597 |
| HLA-DRB1*11:01 | DSKVGGNYNYLYRLFRK | DSKVGGNYNYRYRLFRK | 133 | 541 |
| HLA-DRB1*11:01 | SKVGGNYNYLYRLFR | SKVGGNYNYRYRLFR | 144 | 581 |
| HLA-DRB1*11:01 | DSKVGGNYNYLYRLFR | DSKVGGNYNYRYRLFR | 357 | 1364 |
| HLA-DRB1*11:01 | SKVGGNYNYLYRLFRKSN | SKVGGNYNYRYRLFRKSN | 281 | 1070 |
| HLA-DRB1*11:01 | LDSKVGGNYNYLYRLFR | LDSKVGGNYNYRYRLFR | 344 | 1295 |
| HLA-DRB1*11:01 | KVGGNYNYLYRLFRKS | KVGGNYNYRYRLFRKS | 114 | 416 |
| HLA-DRB1*11:01 | DSKVGGNYNYLYRLFRKSN | DSKVGGNYNYRYRLFRKSN | 134 | 485 |
| HLA-DRB1*11:01 | VGGNYNYLYRLFRKS | VGGNYNYRYRLFRKS | 50 | 179 |
| HLA-DRB1*11:01 | SKVGGNYNYLYRLFRKS | SKVGGNYNYRYRLFRKS | 102 | 357 |
| HLA-DRB1*11:01 | DSKVGGNYNYLYRLFRKS | DSKVGGNYNYRYRLFRKS | 383 | 1300 |
| HLA-DRB1*11:01 | LDSKVGGNYNYLYRLFRKSN | LDSKVGGNYNYRYRLFRKSN | 83 | 278 |
| HLA-DRB1*11:01 | NLDSKVGGNYNYLYRLFRK | NLDSKVGGNYNYRYRLFRK | 258 | 850 |
| HLA-DRB1*11:01 | LDSKVGGNYNYLYRLFRKS | LDSKVGGNYNYRYRLFRKS | 185 | 559 |
| HLA-DRB1*11:01 | NNLDSKVGGNYNYLYRLFRK | NNLDSKVGGNYNYRYRLFRK | 176 | 498 |
| HLA-DRB1*11:01 | NLDSKVGGNYNYLYRLFRKS | NLDSKVGGNYNYRYRLFRKS | 118 | 331 |
Reference VNNSYECDIPIGAGICASYQTQTNSPRRARSVASQSIIAYTMSLGAENSVA
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated VNNSYECDIPIGAGICASYQTQTNSRRRARSVASQSIIAYTMSLGAENSVA
| Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
|---|---|---|---|---|
| HLA-DRB1*11:01 | YQTQTNSPRRARSVA | YQTQTNSRRRARSVA | 1740 | 414 |
| HLA-DRB1*11:01 | SYQTQTNSPRRARSV | SYQTQTNSRRRARSV | 1303 | 360 |
| HLA-DRB1*11:01 | SYQTQTNSPRRARSVASQSI | SYQTQTNSRRRARSVASQSI | 1338 | 399 |
| HLA-DRB1*11:01 | CASYQTQTNSPRRARSVASQ | CASYQTQTNSRRRARSVASQ | 1371 | 421 |
| HLA-DRB1*11:01 | ASYQTQTNSPRRARSVASQS | ASYQTQTNSRRRARSVASQS | 1320 | 407 |
| HLA-DRB1*11:01 | ICASYQTQTNSPRRARSVAS | ICASYQTQTNSRRRARSVAS | 1365 | 443 |
| HLA-DRB1*11:01 | ASYQTQTNSPRRARS | ASYQTQTNSRRRARS | 1184 | 394 |
| HLA-DRB1*11:01 | YQTQTNSPRRARSVASQSII | YQTQTNSRRRARSVASQSII | 1315 | 438 |
| HLA-DRB1*11:01 | GICASYQTQTNSPRRARSVA | GICASYQTQTNSRRRARSVA | 1397 | 484 |
| HLA-DRB1*11:01 | CASYQTQTNSPRRAR | CASYQTQTNSRRRAR | 1341 | 484 |
| HLA-DRB1*11:01 | QTQTNSPRRARSVASQSIIA | QTQTNSRRRARSVASQSIIA | 1351 | 495 |
Reference NNVGPKVYPIILRLGSPLSLNMARKTLNSLEDKAFQLTPIAVQMTKLATTE
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated NNVGPKVYPIILRLGSPLSLNMARKALNSLEDKAFQLTPIAVQMTKLATTE
| Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
|---|---|---|---|---|
| HLA-DRB1*11:01 | SLNMARKTLNSLEDKAFQL | SLNMARKALNSLEDKAFQL | 977 | 321 |
| HLA-DRB1*11:01 | RLGSPLSLNMARKTLNSL | RLGSPLSLNMARKALNSL | 492 | 165 |
| HLA-DRB1*11:01 | SLNMARKTLNSLEDKA | SLNMARKALNSLEDKA | 520 | 175 |
| HLA-DRB1*11:01 | GSPLSLNMARKTLNSLED | GSPLSLNMARKALNSLED | 507 | 172 |
| HLA-DRB1*11:01 | LGSPLSLNMARKTLNSLE | LGSPLSLNMARKALNSLE | 501 | 170 |
| HLA-DRB1*11:01 | SLNMARKTLNSLEDKAF | SLNMARKALNSLEDKAF | 407 | 141 |
| HLA-DRB1*11:01 | LSLNMARKTLNSLEDKAFQ | LSLNMARKALNSLEDKAFQ | 348 | 121 |
| HLA-DRB1*11:01 | LRLGSPLSLNMARKTLNS | LRLGSPLSLNMARKALNS | 825 | 287 |
| HLA-DRB1*11:01 | PLSLNMARKTLNSLEDKAF | PLSLNMARKALNSLEDKAF | 212 | 74 |
| HLA-DRB1*11:01 | SPLSLNMARKTLNSLEDK | SPLSLNMARKALNSLEDK | 552 | 193 |
| HLA-DRB1*11:01 | PLSLNMARKTLNSLEDKA | PLSLNMARKALNSLEDKA | 667 | 234 |
| HLA-DRB1*11:01 | SLNMARKTLNSLEDKAFQLT | SLNMARKALNSLEDKAFQLT | 621 | 218 |
| HLA-DRB1*11:01 | LSLNMARKTLNSLEDKAF | LSLNMARKALNSLEDKAF | 933 | 334 |
| HLA-DRB1*11:01 | SPLSLNMARKTLNSLEDKA | SPLSLNMARKALNSLEDKA | 175 | 63 |
| HLA-DRB1*11:01 | LGSPLSLNMARKTLNSLED | LGSPLSLNMARKALNSLED | 152 | 55 |
| HLA-DRB1*11:01 | GSPLSLNMARKTLNSLEDK | GSPLSLNMARKALNSLEDK | 157 | 57 |
| HLA-DRB1*11:01 | RLGSPLSLNMARKTLNSLE | RLGSPLSLNMARKALNSLE | 153 | 56 |
| HLA-DRB1*11:01 | LRLGSPLSLNMARKTLNSL | LRLGSPLSLNMARKALNSL | 163 | 60 |
| HLA-DRB1*11:01 | LSLNMARKTLNSLEDKAFQL | LSLNMARKALNSLEDKAFQL | 231 | 86 |
| HLA-DRB1*11:01 | LSLNMARKTLNSLEDKA | LSLNMARKALNSLEDKA | 142 | 54 |
| HLA-DRB1*11:01 | SLNMARKTLNSLEDK | SLNMARKALNSLEDK | 168 | 64 |
| HLA-DRB1*11:01 | PLSLNMARKTLNSLEDK | PLSLNMARKALNSLEDK | 102 | 39 |
| HLA-DRB1*11:01 | LSLNMARKTLNSLEDK | LSLNMARKALNSLEDK | 168 | 65 |
| HLA-DRB1*11:01 | RLGSPLSLNMARKTLNS | RLGSPLSLNMARKALNS | 136 | 53 |
| HLA-DRB1*11:01 | PLSLNMARKTLNSLEDKAFQ | PLSLNMARKALNSLEDKAFQ | 127 | 50 |
| HLA-DRB1*11:01 | LGSPLSLNMARKTLNS | LGSPLSLNMARKALNS | 167 | 66 |
| HLA-DRB1*11:01 | ILRLGSPLSLNMARKTLNS | ILRLGSPLSLNMARKALNS | 258 | 102 |
| HLA-DRB1*11:01 | PLSLNMARKTLNSLED | PLSLNMARKALNSLED | 126 | 50 |
| HLA-DRB1*11:01 | GSPLSLNMARKTLNSLE | GSPLSLNMARKALNSLE | 83 | 33 |
| HLA-DRB1*11:01 | LGSPLSLNMARKTLNSL | LGSPLSLNMARKALNSL | 80 | 32 |
| HLA-DRB1*11:01 | SPLSLNMARKTLNSLED | SPLSLNMARKALNSLED | 87 | 35 |
| HLA-DRB1*11:01 | GSPLSLNMARKTLNSLEDKA | GSPLSLNMARKALNSLEDKA | 91 | 37 |
| HLA-DRB1*11:01 | SPLSLNMARKTLNSLE | SPLSLNMARKALNSLE | 110 | 45 |
| HLA-DRB1*11:01 | GSPLSLNMARKTLNSL | GSPLSLNMARKALNSL | 100 | 41 |
| HLA-DRB1*11:01 | LGSPLSLNMARKTLNSLEDK | LGSPLSLNMARKALNSLEDK | 85 | 35 |
| HLA-DRB1*11:01 | SPLSLNMARKTLNSLEDKAF | SPLSLNMARKALNSLEDKAF | 102 | 42 |
| HLA-DRB1*11:01 | RLGSPLSLNMARKTLN | RLGSPLSLNMARKALN | 344 | 143 |
| HLA-DRB1*11:01 | LGSPLSLNMARKTLN | LGSPLSLNMARKALN | 143 | 60 |
| HLA-DRB1*11:01 | LRLGSPLSLNMARKTLN | LRLGSPLSLNMARKALN | 269 | 113 |
| HLA-DRB1*11:01 | RLGSPLSLNMARKTLNSLED | RLGSPLSLNMARKALNSLED | 83 | 35 |
| HLA-DRB1*11:01 | LRLGSPLSLNMARKTLNSLE | LRLGSPLSLNMARKALNSLE | 85 | 36 |
| HLA-DRB1*11:01 | ILRLGSPLSLNMARKTLNSL | ILRLGSPLSLNMARKALNSL | 96 | 42 |
| HLA-DRB1*11:01 | LNMARKTLNSLEDKA | LNMARKALNSLEDKA | 944 | 413 |
| HLA-DRB1*11:01 | GSPLSLNMARKTLNS | GSPLSLNMARKALNS | 66 | 29 |
| HLA-DRB1*11:01 | LSLNMARKTLNSLED | LSLNMARKALNSLED | 63 | 28 |
| HLA-DRB1*11:01 | IILRLGSPLSLNMARKTLNS | IILRLGSPLSLNMARKALNS | 133 | 61 |
| HLA-DRB1*11:01 | SPLSLNMARKTLNSL | SPLSLNMARKALNSL | 42 | 20 |
| HLA-DRB1*11:01 | PLSLNMARKTLNSLE | PLSLNMARKALNSLE | 47 | 23 |
Reference KDAPYIVGDVVQEGVLTAVVIPTKKAGGTTEMLAKALRKVPTDNYITTYPG
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated KDAPYIVGDVVQEGVLTAVVIPTKKSGGTTEMLAKALRKVPTDNYITTYPG
| Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
|---|---|---|---|---|
| HLA-DRB1*11:01 | LTAVVIPTKKAGGTTEMLAK | LTAVVIPTKKSGGTTEMLAK | 474 | 983 |
Reference CVNCLDDRCILHCANFNVLFSTVFPPTSFGPLVRKIFVDGVPFVVSTGYHF
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated CVNCLDDRCILHCANFNVLFSTVFPLTSFGPLVRKIFVDGVPFVVSTGYHF
| Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
|---|---|---|---|---|
| HLA-DRB1*11:01 | STVFPPTSFGPLVRK | STVFPLTSFGPLVRK | 2376 | 314 |
| HLA-DRB1*11:01 | FSTVFPPTSFGPLVRKI | FSTVFPLTSFGPLVRKI | 2923 | 409 |
| HLA-DRB1*11:01 | TVFPPTSFGPLVRKI | TVFPLTSFGPLVRKI | 1773 | 257 |
| HLA-DRB1*11:01 | FSTVFPPTSFGPLVR | FSTVFPLTSFGPLVR | 2949 | 493 |
| HLA-DRB1*11:01 | LFSTVFPPTSFGPLVRK | LFSTVFPLTSFGPLVRK | 2782 | 492 |
| HLA-DRB1*11:01 | NVLFSTVFPPTSFGPLVRKI | NVLFSTVFPLTSFGPLVRKI | 1267 | 408 |
| HLA-DRB1*11:01 | TVFPPTSFGPLVRKIF | TVFPLTSFGPLVRKIF | 902 | 293 |
| HLA-DRB1*11:01 | STVFPPTSFGPLVRKIF | STVFPLTSFGPLVRKIF | 729 | 240 |
| HLA-DRB1*11:01 | LFSTVFPPTSFGPLVRKIF | LFSTVFPLTSFGPLVRKIF | 1150 | 447 |
| HLA-DRB1*11:01 | FNVLFSTVFPPTSFGPLVRK | FNVLFSTVFPLTSFGPLVRK | 1200 | 468 |
| HLA-DRB1*11:01 | VFPPTSFGPLVRKIF | VFPLTSFGPLVRKIF | 292 | 125 |
| HLA-DRB1*11:01 | VLFSTVFPPTSFGPLVRKIF | VLFSTVFPLTSFGPLVRKIF | 625 | 279 |
| HLA-DRB1*11:01 | VFPPTSFGPLVRKIFVD | VFPLTSFGPLVRKIFVD | 387 | 176 |
| HLA-DRB1*11:01 | NVLFSTVFPPTSFGP | NVLFSTVFPLTSFGP | 708 | 336 |
| HLA-DRB1*11:01 | TVFPPTSFGPLVRKIFV | TVFPLTSFGPLVRKIFV | 324 | 157 |
| HLA-DRB1*11:01 | FPPTSFGPLVRKIFVDG | FPLTSFGPLVRKIFVDG | 428 | 208 |
| HLA-DRB1*11:01 | VFPPTSFGPLVRKIFV | VFPLTSFGPLVRKIFV | 413 | 203 |
| HLA-DRB1*11:01 | FPPTSFGPLVRKIFVD | FPLTSFGPLVRKIFVD | 492 | 245 |